Indication
Primary Generalized Tonic Clonic Seizures
1 clinical trial
1 product
Clinical trial
A Multicenter Open-Label Extension Study to Evaluate the Long-Term Safety of Cenobamate Adjunctive Therapy in Subjects With Primary Generalized Tonic-Clonic SeizuresStatus: , Estimated PCD: 2025-05-01
Product
Cenobamate